GlassScriptPhysician profile
Jesus Tan
NPI 1396715769
$356.11
in general payments reported to CMS, 2019-2025
8 companies · $24.10 in 2025
The $24.10 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $28.84 · 2021: $75.31 · 2022: $24.32 · 2023: $38.79 · 2024: $20.14 · 2025: $24.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $158.25 | 2021-2025 | Dupixent |
| Lilly USA, LLC | $57.21 | 2019-2020 | |
| Novo Nordisk INC | $48.99 | 2019 | |
| Pfizer INC. | $29.31 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $24.41 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.18 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.52 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesus Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.